Abstract
Chimeric antigen receptor (CAR) T-cell therapy for malignant tumors has reached a crucial stage, with recent studies underscoring the role of T-cell exhaustion in determining the efficacy of CAR-T ... Plain language summary Chimeric antigen receptor (CAR) T-cell therapy, a treatment that boosts the body's immune system to fight cancer, has made significant progress. Recent research has shown tha...
Funding Information
  • National Key Research and Development Program of China (2023YFC2505900)
  • National Natural Science Foundation of China (81873874, 82071797)

This publication has 52 references indexed in Scilit: